Survival Rates of the 5 Major Cancers in Jeju Island Residents, 2000-2001

2000-2001년도 제주도민 주요 5대 암 생존율

  • Yang, Yeong-Ja (Department of Preventive Medicine, Cheju National University College of Medicine & Jejudo Regional Cancer Registry) ;
  • Bae, Jong-Myon (Department of Preventive Medicine, Cheju National University College of Medicine & Jejudo Regional Cancer Registry)
  • 양영자 (제주대학교 의과대학 예방의학교실 및 제주도지역암등록본부) ;
  • 배종면 (제주대학교 의과대학 예방의학교실 및 제주도지역암등록본부)
  • Published : 2007.05.31

Abstract

Objectives : This study aimed to calculate the survival rates of cancer patients in Jeju Island residents from 2000 to 2001, based on their major primary sites of occurrence. Methods : Data were extracted from the database of the Jejudo Cancer Registry (JCR). The eligible population comprised 2,382 cancer cases, whose cancers were diagnosed from 1 January 2000 through 31 December 2001. Of the eligible population, 1,438 patients with 5 major cancers defined by the level of incidence rates were selected as the study participants. The period of survival for each case was calculated from the date of first diagnosis to the date of death, or the end of follow-up, i.e., 31 December 2003. The observed survival rates (OSR) and relative survival rates (RSR) were calculated according to sex, age-group, and primary sites of occurrence. Results : The 3-year OSR and RSR in 5 major cancers were higher in women than in men except 75 year-old over group. The 3-year RSR of stomach, colorectum, liver, and lung in both sexes were 61.0%, 62.6%, 24.7%, and 22.8%, respectively. The respective rates in JCR showed some statistically significant differences from those in the Korea Central Cancer Registry (KCCR). Conclusions : These results would suggest some clues about prognostic factors of major cancers in Korean, and could apply to planning and evaluating of cancer control strategies in Jeju Island.

Keywords

References

  1. Korea National Statistical Office. 2004 Annual Report on the Cause of Death Statistics. Korea National Statistical Office; 2005. p. 30
  2. Jejudo Regional Cancer Registry. 2004 Jejudo Regional Cancer Registry. Jejudo Regional Cancer Registry; 2004. p. 73
  3. WHO. National Cancer Control Programmes- Policies and Managerial Guidelines, 2nd ed. Geneva: WHO; 2004. p. 172
  4. Mao Y, Morrison H, Semenciw R, Robson D, Wigle D. The prevalence of cancer in canada. Can J Public Health 1991; 82(1): 61-62
  5. Coldman AJ, McBride ML, Braun T. Calculating the prevalence of cancer. Stat Med 1992; 11(12): 1579-1589 https://doi.org/10.1002/sim.4780111205
  6. Lee SW, Ohrr HC, Lee KH, Kim SI, Kang HG, Jee SH. The prevalence of cancer in Kangwha county. J Prev Med Health 1999; 32(3): 333- 342 (Korean)
  7. Korea Cancer Registry. 2004 Manual for Cancer Registration. Korea Cancer Registry; 2004. p. 31-36
  8. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38(4): 933-942 https://doi.org/10.2307/2529873
  9. Hakulinen T, Tenkanen L. Regression analysis of relative survival rates. Applied Statistics 1987; 36(3): 309-317 https://doi.org/10.2307/2347789
  10. Dickman P, Hakulinen T. Population-based Cancer Survival Analysis. John Wiley and Sons Ltd; 2003. p. 1-112
  11. National Cancer Center. Survival of Korean Cancer Patients. National Cancer Center; 2002. p. 46
  12. Kim SY, Ohrr HC, Kang HG, Kim SI, Lee SW. Cancer incidence in Kangwha county (1986-1992). J Prev Med Health 1999; 32(4): 482-490 (Korean)
  13. Park CT, Lee KJ, Seong SJ, Kim KT, Chung HW, Park IS, Shim JU, Lee KH. Clinico- pathologic profiles and 5-year survival rate of 2209 patients with invasive cancer of the uterine cervix. Korean J Obstet Gynecol 2003; 46(7): 1404-1410 (Korean)
  14. Clake EA. Does screening by 'Pap' smear help prevent cervix cancer? A case-control study. Lancet 1979; 2(8132): 1-4
  15. Geirsson G, Kristiansdottir R, Sigurdsson K, Moss S, Tulinius H. Cervical cancer screening in Iceland: a case-control study. IARC Sci Publ. 1986; (76): 37-41
  16. Shapiro S. Evidence of screening for breast cancer from a randomized trial. Cancer 1977; 39(6 suppl): 2772-2782 https://doi.org/10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K